ECAT Branch - Philadelphia
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- SPE2DE21R0003
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2DE21D0023 Federal IDV award
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
Notice details come from SAM.gov. Updated .
About this opportunity
This Limited/Sole Source Justification Notice from the Defense Logistics Agency Troop Support Medical Supply Chain provides the rationale for awarding a contract on a sole source basis to Abbott Rapid Dx North America, LLC. The contract is for an estimated 50 million FDA-authorized point-of-care lateral flow antigen tests to detect SARS-CoV-2 and 8,000 control kits, with a period of performance from March 8, 2021 through November 8, 2021. At estimated prices of $5.10 per test and $60 per control kit, the contract has an estimated value of $255,480,000 and maximum value of $766,440,000. The antigen tests will support nursing homes and long term care facilities in complying with Centers for Medicare and Medicaid Services rules for resident and staff COVID-19 testing.
Attachments
| File | Type | Posted |
|---|---|---|
| Tab 1- Antigen Test JA Finalvgf with DG Signature 3-24-21 EC Redactions v3_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| ECAT Branch - Philadelphia | Limited / Sole Source Justification | |
| ECAT Branch - Philadelphia | Award Notice |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity